Leslie M. Randall

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro et al. · Journal of Clinical Oncology · 2019 · 483 citations · Full text

Medicine, Gynecology, Oncology +12

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 394 citations

Medicine, Oncology, Pharmacotherapy +13

Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial

Bradley J. Monk, Nicoletta Colombo, Amit M. Oza et al. · The Lancet Oncology · 2021 · 284 citations · Full text

Medicine, Gynecology, Oncology +11

High-volume ovarian cancer care: Survival impact and disparities in access for advanced-stage disease

Robert E. Bristow, Jenny Chang, Argyrios Ziogas et al. · Gynecologic Oncology · 2013 · 169 citations · Full text

Medicine, Gynecology, Oncology +16

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006)

János L. Tanyi, Leslie M. Randall, Setsuko K. Chambers et al. · Journal of Clinical Oncology · 2022 · 166 citations · Full text

Medicine, Gynecology, Oncology +17